COVERAGE MANAGEMENT PROGRAMS
The purpose of coverage management programs is to help improve the quality of care by
encouraging the right patient and provider behaviors to avoid compromised care and unnecessary
costs.
How coverage management works
Certain medications may require approval through a coverage review before they will be covered.
This review uses plan rules based on FDA-approved prescribing and safety information, clinical
guidelines, and uses that are considered reasonable, safe, and effective. There are three different
coverage management programs under your plan: Prior Authorization, Qualification by
History (Step Therapy), and Quantity Management.
During a coverage review, Express Scripts contacts your doctor for more information before the
medication will be covered under your plan. If you know in advance that your prescription
requires a coverage review, ask your doctor to call the coverage review team before you go to the
pharmacy. This call will initiate a review, which typically takes one to two business days. Once
the review is complete, Express Scripts will send a letter to notify you and your doctor of its
decision. If the review is approved, the letter will tell you the length of your coverage approval. If
coverage is denied, the letter will include the reason for coverage denial and instructions on how
to submit an appeal.
The coverage review process
To save you time and help avoid any confusion, we’d like to highlight the coverage review
process, both at a retail pharmacy and through mail order.
At a retail pharmacy in your plan’s network:
 You take the prescription to your local pharmacist, who submits the information to Express
Scripts. If a coverage review is necessary, Express Scripts automatically notifies the
pharmacist, who in turn tells you that the prescription needs to be reviewed or requires
“prior authorization.”

As an enrolled member, you, the pharmacist, or your doctor may start the review process
by calling directly the Express Scripts managed care department toll-free at (800) 7532851, 8:00 a.m. to 9:00 p.m., eastern time, Monday through Friday.

Express Scripts contacts your doctor requesting more information than what is on the
prescription. After receiving the necessary information, Express Scripts notifies you and
the doctor (usually within 1 to 2 business days) confirming whether or not coverage has
been approved.

If coverage is approved, you simply pay your normal coinsurance for the medication. If
coverage is not approved, you will be responsible for the full cost of the medication or, if
appropriate, you can talk to your doctor about alternatives that may be covered. (You have
the right to appeal the decision. Information about the appeal process will be included in
the letter that you receive.)

Special note: If your plan has a limit on the amount of medication covered, your pharmacist
can fill your prescription up to the amount allowed. If the prescription exceeds the amount
covered by your plan, Express Scripts will alert the pharmacist whether a coverage review
is available to obtain an additional amount.
continued…
Through the Express Scripts Pharmacy®, your mail-order service:

You mail the prescription to Express Scripts.

If a coverage review is necessary to obtain coverage for the medication, Express Scripts
contacts your doctor, requesting more information than what is on the prescription. After
receiving the necessary information, Express Scripts notifies you and the doctor (usually
within 1-2 business days), confirming whether or not coverage has been approved.

If coverage is approved, you receive your medication and simply pay your normal
coinsurance for the medication. If coverage is not approved, the prescription is returned to
you. (You have the right to appeal the decision. Information about the appeal process will
be included in the letter that you receive.)

Special note: If your plan has a limit on the amount of medication, then Express Scripts
will only dispense the amount allowed. Express Scripts will send you a statement that
explains the limit and tells you whether a coverage review is available to obtain an
additional amount.
Below is a list of each coverage management program with the corresponding partial list of
medications. To find out more about coverage reviews, prior authorization, and coverage on your
medications, please call the LM HealthWorks Plan at (877) 458-4975. Member Services will
assist with drug coverage and any questions you may have before connecting the caller (your
pharmacist, doctor or yourself) to the managed care department to initiate the case.
Prior Authorization—Some medications require that you obtain approval through a coverage
review before the medication can be covered under your plan. The coverage review process will
allow the benefit manager to obtain information not available on your original prescription to
determine whether a given medication qualifies for coverage under your plan. Medications are
periodically added to these programs when new FDA-approved drugs become available. If you
are getting the prescription filled through a retail pharmacy, your pharmacist will be notified that
the drug cannot be filled without prior approval and that your physician must call to get approval
for the prescription.
 Actinic keratoses (Solaraze®)
 Allergy (Grastek®, Oralair®, Ragwitek®)
 Androgens & Anabolic Steroids (Anroderm®, AndroGel®, Axiron®, Aveed®, Fortesta®,
Striant®, Testim®, First® Testostrone, Injectable Testosterone) (Preferred Step Therapy also
applies)
 Alpha 1 Proteinase Inhibitors (Aralast®, Glassia®, Prolastin®, Zemaira®) (Preferred Step
Therapy also applies)

Antinarcoleptics (Nuvigil®, Provigil®)

Antiviral Agents (Daklinza®,Harvoni®, Olysio ®, Sovaldi ®, Technivie®,
Viekira®)(Preferred Step Therapy and Quantity Management also apply
Antiviral Agents (Copegus ®, Rebetol ®, Ribasphere ®)
Bile Acids (Chenodal®)
Blood disorders- phenylketonuira agents (Kuvan ®)
Blood disorders- thrombocytopenia (NPlate ®, Promacta®)






Cholesterol Lowering Agents (Lovaza®, Vescepa® )
Chronic obstructive pulmonary disease (Daliresp®)


Cosmetics - Botulinum (Botox®, Dysport®, Mybloc®, Xeomin®)
Cryopyrin-Associated Periodic Syndrome Agents (Arcalyst®, Ilaris®) (Preferred Step Therapy
also applies)
Dermatologicals - Topical Tretinoins/Tazorac (Atralin®, Avita®, Fabicor®,Retin A®, Tretin
X®, Tazorac®, Veltin®, Ziana®)




Erythroid Stimulants (Aranesp®. Epogen®,Mircera®, Procrit®) (Preferred Step Therapy also
applies)
Eye Conditions (Restasis)
Growth Hormones (Egrifta®, Genotropin®, Humatrope®, Increlex®, Norditropin Novo
Nordisk®, Nutropin®, Nutropin AQ®, Omnitrope®, Saizen®, Serostim®, Tev-Tropin®,
Zorbtive®) (Preferred Step Therapy also applies)


Hyaluronic Acid Derivatives (Euflexxa®, Gel-One®, Hyalgan®,Monovisc® Orthovisc®,
Supartz®, Synvisc®, Synvisc- One®)
 Idiopathic Pulmonary Fibrosis (Esbriet®,Ofev®)
 Immune Globulins (Bivigam®, Carimune®, Gammagard®, Gammaked®, Gammunex®,
Hizentra®,Hyqvia®, Octagam®, Privigen®, Vivaglobin®)
 Interferons (Pegasys®, PegIntron®)
 Korlym®
 Leuprolide long acting (Eligard®,Lupaneta®, Lupron®)
 Lipodystrophy (Myalept®)
 Macular Degeneration Agents (Eylea®, Lucentis®, Macugen®)
 Melatonin receptor agonist (Hetlioz®)
 Metabolic Disorders (Cholbam®)
 Misc. (Samsca®)
 Misc. Enzymes (Krystexxa®)
 Misc.Hormones (Acthar Gel®)
 Misc. Hormone (Makena®)
 Misc. Hormone (Natpara®)
 Multiple Sclerosis Agents (Ampyra® , Avonex®, Betaseron®, Copaxone®, Extavia®,
Lemtrada®, Plegridy®,Rebif®, Tysabri®) (Preferred Step Therapy and Quantity Management
also apply)
 Myeloid Stimulants (Granix®, Neulasta®, Neupogen®)
 Neurogenic Orthostatic Hypotension (Northera®)






Neurological Agents (Xenazine®)
Osteoporosis (Boniva®, Forteo®, Prolia®, Reclast®)
Psoriasis Therapy (Cosentyx®,Otezla®,Stelara®)
Pulmonary Agents – Asthma (Xolair ®)
Pulmonary Agents - Hereditary Angioedema (Berinert®, Cinryze®, Firazyr®, Kalbitor®)
(Quantity Management also applies)
Pulmonary Arterial Hypertension (Adcira®, Adempas®,Flolan®, Letairis®, Opsumit ®,
Orenitram®, Remodulin®, Revatio®, Tracleer®, Tyvaso®, Veletri®, Ventavis®) (Preferred
Step Therapy and Quantity Management also apply






Rheumatoid arthritis therapy Agents (Actema®, Cimzia®, Enbrel®, Humira®, Kineret®,
Orencia®, Remicaide®, Rituxan®, Simponi®) (Preferred Step Therapy and Quantity
Management also apply)
RSV Agents (Synagis®)
Topical Anesthetic (Lidoderm®)
Ulcerative Colitis and Crohn’s (Entyvio®)
Weight Loss Drugs (Adipex®, Belviq®,Bontril®,Contrave®, Didrex®, Qsymia®, Sanorex®,
Suprenza®, Tenuate®, Xenical®,
Step Therapy—Some medications may require to first try one or more specified drugs to treat a
particular condition before the plan will cover another (usually more expensive) drug that your
doctor may have prescribed. In these cases, a coverage review will be required if certain criteria
cannot be determined from past history.
Step therapy is intended to reduce costs to you and your plan by encouraging use of medications
that are less expensive but can still treat your condition effectively. If you know in advance that
your prescription requires a coverage review, ask your doctor to call the coverage management
team before you go to the pharmacy.
To see which medications are affected by step therapy, please visit www.express-scripts.com or
call Express Scripts Member Services.












Angiotensin II Receptor Blockers (Atacand/Atacand HCT®, Avalide®, Avapro®, Azor®,
Benicar/Benicar HCT®,Cozaar®, Diovan®/Diovan HCT® , Edarbi®, Edarbyclor®, Exforge
HCT®, Hyzaar®, Micardis/Micardis HCT ®, Teveten/®Teveten HCT® , Twynsta®,
Tribenzor®)
Benign Prostatic Hyperplasia Agents (Avodart®, dutasteride/tamsulosin, Proscar®, Jalyn®)
Bisphosphonates (Actonel®,Actonel Plus D ®, Atelvia®, Binosto®, Boniva®, Fosamax l®,
Fosamax D®)
COX2 Inhibitors (Celebrex®)
Fenofibrates (Antara®, Fenoglide®, Fibricor®, Lipofen®, Lofibra®, Tricor®, Triglide®,
Triliprix®
Infertility Drugs (Bravelle ®, Follistim AQ ®, Ganirelix®
Inhaled Corticosteroids (Aerospan®, Alvesco®, Arnuity Ellipta®, Flovent Diskus/HFA®)
Misc. Agents (Alcortin A®,Android®,Amrix®, Astagraf XL®, Flowtuss®,
Hycofenix®,Lidocaine-Tetracaine 7% Cream®, Livixil Pak®, Lorzone®, Oleptro ER®,
Procysbi DR ®, Rayos DR ®, Relador/ Plus ®, Sitavig Buccal®, Tussicaps ®, Tuzistra XR ®,
Vituz ®, Zyflo/CR ®)
Nasal Steroids (Beconase AQ®, Dymista®, Flonase®, Nasacort®,Nasare®l,Nasonex® ,
Omnaris®, Omnaris®, Qnas®, lRhinocort Aqua®, Veramyst®, Zetona®)
Non Steroidal Anti Inflamatory Drugs (Ansaid ®, Arthrotec®, Cambia®,Cataflam ®,Clinoril ®,
Daypro ®, Duexis®, Flector®, Feldene®, Indocin ®, Mobic®, Motrin ®, Nalfon ®,Naprelan
®, Naprosyn ®, Pennsaid®, Ponstel®, Sprix ®, Tivorbex ®, Vimovo®, Voltaren/Gel®,
Zipsor® -Zorvolvex ®))
Ophthalmic Antiallergy Agents (Alocril®, Alomide®, Alamast®,Alrex®, Bepreve®, Elestat®,
Emadine®, Lastacaft®, Optivar®, Pataday®, Patanol®
Overactive bladder Agents (Detrol/LA®, Ditropan/XL®, Enablex®, Genique® , Mybetriq®








,Oxytrol®, Sanctura/XR®, Toviaz®, Vesicare®,
Prostate Cancer Analogs (Frimagon®, Lupron Depot®, Trelstar/Depot®)
Proton Pump Inhibitors (Aciphex ®, Dexilant ®, esomeprazole strontium, Nexium ®,
Prevacid®, Prilosec®, Protonix ®, Zegerid®)
Sedative Hypnotics (Ambien/CR®, Edluar®, Intermezzo®, Lunesta®, Rozerem®, Silenor®,
Sonata®, Zolpimist®)
Tetracyclines- oral (Adoxa®, Doryx®, Dynacyn®, Monodox®, Ocudox®, Oracea®, Oraxyl®,
Periostat®, Solodyn®, Sumycin®, Vibramycin®)
Topical Acne Agents (brand topical benzyl peroxide agents, topical antibiotics, topical
cleansers, kits, ect)
Topical Antifungal Agents (Ciclodan 8% Kit®, CNL 8 Nail Kit®, Jublia®, Kerydin®,
Pedipirox-4 Nail Kit®, Penlac®)
Topical Corticosteroid Agents (Aclovate®, Clobex®, Elocon®, Kenolog®, Locoid®, Luxiq®,
Olux®, Dermatopp/AF®, Ultavate®, ect)
Topical Immunomodulators (Elidel®, Protopic®, generic tacrolimus ointment®)
Quantity Management—To ensure safe and effective drug therapy, certain covered medications
may have quantity restrictions. These quantity restrictions are based on manufacturer and/or
clinically approved guidelines and are subject to periodic review and change. Some examples
include antimigraine drugs, rheumatoid arthritis and osteoarthritis drugs, impotence drugs,
sedative hypnotics, and pain management drugs.
 Allergies (Non sedating antihistamines, Nasal Steroids)
 Anaphylaxis
 Anti- influenza
 Antiemetic Agents
 Antifungal
 Antiviral Agents
 Asthma
 Blood Cell Deficiency
 Bone Conditions
 Contraceptives
 Chronic obstructive pulmonary disease
 Diabetic Agents - Byetta/Symlin/Victoza
 Endocrine Disorders
 Erectile Dysfunction Agents
 Eye Conditions (Restasis)
 Fertility Agents
 Hepatitis C
 High Blood Cholesterol
 High Blood Pressure
 Hormone Supplementation
 Hypnotic Agents
 Migraine Therapy
 Narcotic Analgesics/Pain
 Overactive bladder



Pulmonary Agents - Cystic Fibrosis
Wound Care
Ulcers
\
NOTE: The information outlined above is accurate as of 1/1/2016; however, it is subject to
change. Please call Member Services at (877) 458-4975 if you have any questions or for further
verification.